MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.ijpharm.2023.123443

Медицинская библиотека · International journal of pharmaceutics · 2023

Subconjunctival therapy by cubic liquid crystalline nanoparticles to deliver Triamcinolone acetonide for the management of diabetic Retinopathy: In vivo evidences.

Sharadha M, Vishal Gupta N, Rahamathulla Mohamed, Muqtader Ahmed Mohammed, Ayesha Farhana Syeda, Osmani Riyaz Ali M, Veeranna Balamuralidhara, Koteshwara K B

СтатьяПеревод пока не подготовлен

Аннотация

The expression of inflammatory markers and vascular endothelial growth factor (VEGF) was found to be upregulated in various posterior ocular disorders, including diabetic retinopathy (DR). Effective delivery of therapeutic agents to the retina poses a significant challenge in ophthalmic drug delivery due to biological ocular barriers. Triamcinolone acetonide (TA) was selected as the model corticosteroid drug targeting cytokines and VEGF in DR. However, despite TA's low molecular weight and hydrophobicity, which enable it to bypass the conjunctival epithelial barrier, it doesn't efficiently exert its effect at the target site. Nanocarriers have emerged as a solution to enhance drug delivery to the retina and improve bioavailability. This study aimed to compare the effects of Triamcinolone-loaded cubic liquid crystalline nanoparticles (TA-cubic LCNPs) and TA-Suspension in an experimental DR model administered via the subconjunctival (SCJ) route. The results demonstrated that TA-cubic LCNPs enhanced TA periocular delivery efficacy by reducing inflammatory and VEGF markers through the advanced glycation end products (AGE)/protein kinase C pathway. They were identified as promising nano-carriers, exhibiting potential for targeted delivery to the retina.

Для цитирования: Sharadha M, Vishal Gupta N, Rahamathulla Mohamed, Muqtader Ahmed Mohammed, Ayesha Farhana Syeda, Osmani Riyaz Ali M, Veeranna Balamuralidhara, Koteshwara K B. Subconjunctival therapy by cubic liquid crystalline nanoparticles to deliver Triamcinolone acetonide for the management of diabetic Retinopathy: In vivo evidences.. International journal of pharmaceutics. 2023. DOI: 10.1016/j.ijpharm.2023.123443.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.